エディットフォース
3 known investors
EditForce develops proprietary PPR gene-editing technology that can modify both DNA and RNA, with applications in medicine, agriculture, and chemical industries. The company aims to advance therapeutic drug development and address challenges in health, food, and environmental sectors.
Investors · 3
Frequently asked questions
- What does エディットフォース do?
- EditForce develops proprietary PPR gene-editing technology that can modify both DNA and RNA, with applications in medicine, agriculture, and chemical industries. The company aims to advance therapeutic drug development and address challenges in health, food, and environmental sectors.
- Who are エディットフォース's investors?
- エディットフォース's investors include Global Brain, KDDI Open Innovation Fund, Newton Biocapital.